John McGrath, Chief Financial Officer at Atara Biotherapeutics, Inc. (ATRA), sold 5,000 shares at $18.52 ($87K) on 2016-10-11, disclosed to the SEC on 2016-10-13.
Open-market sale of $87k ATRA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.52 | 2,500 | $46K | 53.0% |
| 2 | $16.41 | 2,500 | $41K | 47.0% |
| Total | $17.46 avg | 5,000 | $87K | 100% |
| Filing → |
| ATRA | SELL | 2018-01-12 | $901K | — | Filing → |
| ATRA | SELL | 2018-01-02 | $640K | — | Filing → |
| ATRA | SELL | 2017-08-17 | $60K | — | Filing → |